Physician profile
Kelly Lynn Moore
NPI 1497965115
$120,699.70
in general payments reported to CMS, 2019-2025
10 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Public Health & General Preventive Medicine providers received nationally (typical 2025 total: $95.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,880 · 2020: $21K · 2021: $16K · 2022: $14K · 2023: $11K · 2024: $29K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $4,687 · Food and Beverage: $2,012 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,435.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,625.00 |
| Travel and Lodging | $4,687.46 |
| Food and Beverage | $2,011.88 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67,717.30 | 2019-2025 | |
| Pfizer International LLC | $18,562.24 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $14,685.60 | 2024-2025 | Capvaxive |
| Seqirus USA INC | $7,593.42 | 2020-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Dynavax Technologies Corporation | $5,400.00 | 2024 | Heplisav-B |
| Sanofi Pasteur INC. | $5,113.29 | 2020-2024 | |
| Modernatx, INC. | $1,455.00 | 2025 | |
| Sanofi US Services INC. | $95.33 | 2023 | |
| Glaxosmithkline, LLC. | $57.00 | 2023 | Arexvy |
| Genzyme Corporation | $20.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.